Lamotrigine ER 300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWZHH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,358
Award facts
- Contract value 100% obligated
- $2,357.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,357.64 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 300 mg tablets (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's federal medical procurement activities.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, supplies a diverse portfolio of medications and medical commodities to military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contracting demonstrates consistent capability in fulfilling pharmaceutical requirements across multiple therapeutic domains, from generic medications to specialty treatments, supporting the Defense Health Agency and other government healthcare customers. This specific delivery order for Lamotrigine—a neurological treatment—represents a routine transaction within the company's broader strategic role as a pharmaceutical prime vendor serving global military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FWZHH?
SPE2DB25FWZHH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FWZHH worth?
The government has obligated $2,358 on SPE2DB25FWZHH.
Is contract SPE2DB25FWZHH an order under another contract?
Yes. SPE2DB25FWZHH is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZHH competed?
The extent of competition for SPE2DB25FWZHH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award